메뉴 건너뛰기




Volumn 10, Issue 2, 2004, Pages 113-119

Inhaled corticosteroids in chronic obstructive pulmonary disease: Is there a long-term benefit?

Author keywords

Chronic bronchitis; Chronic obstructive pulmonary disease; COPD; Emphysema; Inhaled corticosteroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; SALMETEROL; TRIAMCINOLONE;

EID: 1642447018     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200403000-00005     Document Type: Review
Times cited : (14)

References (51)
  • 1
    • 0035035768 scopus 로고    scopus 로고
    • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary
    • Pauwels RA, Buist AS, Calverley PM, et al.: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
    • (2001) Am J Respir Crit Care Med , vol.163 , pp. 1256-1276
    • Pauwels, R.A.1    Buist, A.S.2    Calverley, P.M.3
  • 2
    • 0031020213 scopus 로고    scopus 로고
    • Prehospitalization inhaled corticosteroid use in patients with COPD or asthma
    • Jackevicius C, Joyce DP, Kesten S, et al.: Prehospitalization inhaled corticosteroid use in patients with COPD or asthma. Chest 1997, 111:296-302.
    • (1997) Chest , vol.111 , pp. 296-302
    • Jackevicius, C.1    Joyce, D.P.2    Kesten, S.3
  • 3
    • 0032992798 scopus 로고    scopus 로고
    • Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice
    • EOLO Group
    • Miravitlles M, Mayordomo C, Arles M, et al.: Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Respir Med 1999, 93:173-179.
    • (1999) Respir Med , vol.93 , pp. 173-179
    • Miravitlles, M.1    Mayordomo, C.2    Arles, M.3
  • 4
    • 0033033896 scopus 로고    scopus 로고
    • Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995
    • Van Andel AE, Reisner C, Menjoge SS, et al.: Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995. Chest 1999, 115:703-707.
    • (1999) Chest , vol.115 , pp. 703-707
    • Van Andel, A.E.1    Reisner, C.2    Menjoge, S.S.3
  • 5
    • 0034988161 scopus 로고    scopus 로고
    • Cellular and structural bases of chronic obstructive pulmonary disease
    • Saetta M, Turato G, Maestrelli P, et al.: Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:1304-1309.
    • (2001) Am J Respir Crit Care Med , vol.163 , pp. 1304-1309
    • Saetta, M.1    Turato, G.2    Maestrelli, P.3
  • 6
    • 0037320195 scopus 로고    scopus 로고
    • Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease
    • Fabbri LM, Romagnoli M, Corbetta L, et al.: Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167:418-424.
    • (2003) Am J Respir Crit Care Med , vol.167 , pp. 418-424
    • Fabbri, L.M.1    Romagnoli, M.2    Corbetta, L.3
  • 7
    • 0032696013 scopus 로고    scopus 로고
    • Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease
    • Culpitt SV, Nightingale JA, Barnes PJ: Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:1635-1639.
    • (1999) Am J Respir Crit Care Med , vol.160 , pp. 1635-1639
    • Culpitt, S.V.1    Nightingale, J.A.2    Barnes, P.J.3
  • 8
    • 0031045482 scopus 로고    scopus 로고
    • Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
    • Keatings VM, Jatakanon A, Worsdell YM, et al.: Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997, 155:542-548.
    • (1997) Am J Respir Crit Care Med , vol.155 , pp. 542-548
    • Keatings, V.M.1    Jatakanon, A.2    Worsdell, Y.M.3
  • 9
    • 0034942614 scopus 로고    scopus 로고
    • In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation
    • Loppow D, Schleiss MB, Kanniess F, et al.: In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med 2001, 95:115-121.
    • (2001) Respir Med , vol.95 , pp. 115-121
    • Loppow, D.1    Schleiss, M.B.2    Kanniess, F.3
  • 10
    • 0029972142 scopus 로고    scopus 로고
    • Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
    • Meagher LC, Cousin JM, Seckl JR, et al.: Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996, 156:4422-4428.
    • (1996) J Immunol , vol.156 , pp. 4422-4428
    • Meagher, L.C.1    Cousin, J.M.2    Seckl, J.R.3
  • 11
    • 0034012129 scopus 로고    scopus 로고
    • No effect of inhaled budesonide on the response to inhaled ozone in normal subjects
    • Nightingale JA, Rogers DF, Chung KF, et al.: No effect of inhaled budesonide on the response to inhaled ozone in normal subjects. Am J Respir Crit Care Med 2000, 161:479-486.
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 479-486
    • Nightingale, J.A.1    Rogers, D.F.2    Chung, K.F.3
  • 12
    • 0036727142 scopus 로고    scopus 로고
    • Effects of fluticasone propionate on inflammatory cells in COPD: An ultrastructural examination of endobronchial biopsy tissue
    • Gizycki MJ, Hattotuwa KL, Barnes N, et al.: Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax 2002, 57:799-803. This article reviews the pattern of inflammation found in COPD and the subsequent effects of inhaled fluticasone.
    • (2002) Thorax , vol.57 , pp. 799-803
    • Gizycki, M.J.1    Hattotuwa, K.L.2    Barnes, N.3
  • 13
    • 0037097883 scopus 로고    scopus 로고
    • The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease
    • Hattotuwa KL, Gizycki MJ, Ansari TW, et al.: The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 165:1592-1596. This article reviews the pattern of inflammation found in COPD and the subsequent effects of inhaled fluticasone.
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 1592-1596
    • Hattotuwa, K.L.1    Gizycki, M.J.2    Ansari, T.W.3
  • 14
    • 0034727828 scopus 로고    scopus 로고
    • Lung Health Study Research Group Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease
    • Anonymous: Lung Health Study Research Group Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000, 343:1902-1909.
    • (2000) N Engl J Med , vol.343 , pp. 1902-1909
  • 15
    • 0029866161 scopus 로고    scopus 로고
    • Effects of long-term treatment with corticosteroids in CIOD
    • Renkema TE, Schouten JP, Koeter GH, et al.: Effects of long-term treatment with corticosteroids in CIOD. Chest 1996, 109:1156-1162.
    • (1996) Chest , vol.109 , pp. 1156-1162
    • Renkema, T.E.1    Schouten, J.P.2    Koeter, G.H.3
  • 16
    • 0034643610 scopus 로고    scopus 로고
    • Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
    • Burge PS, Calverley PM, Jones PW, et al.: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000, 320:1297-1303.
    • (2000) BMJ , vol.320 , pp. 1297-1303
    • Burge, P.S.1    Calverley, P.M.2    Jones, P.W.3
  • 17
    • 33748979747 scopus 로고    scopus 로고
    • BTS guidelines for the management of chronic obstructive pulmonary disease
    • British Thoracic Society: BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997, 52(suppl 5):S1-28.
    • (1997) Thorax , vol.52 , Issue.5 SUPPL.
  • 18
    • 0042354673 scopus 로고    scopus 로고
    • Prednisolone response in patients with chronic obstructive pulmonary disease: Results from the ISOLDE study
    • Burge PS, Calverley PMA, Jones PW, et al.: Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax 2003, 58:654-658. This article shows that a trial of corticosteroids does not predict subsequent response to inhaled fluticasone propionate.
    • (2003) Thorax , vol.58 , pp. 654-658
    • Burge, P.S.1    Calverley, P.M.A.2    Jones, P.W.3
  • 19
    • 0032973833 scopus 로고    scopus 로고
    • A double-blind placebo-controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease
    • Weir DC, Bale GA, Bright P, et al.: A double-blind placebo-controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease. Clin Exp Allergy 1999, 20(suppl 2):125-128.
    • (1999) Clin Exp Allergy , vol.20 , Issue.2 SUPPL. , pp. 125-128
    • Weir, D.C.1    Bale, G.A.2    Bright, P.3
  • 20
    • 0033614639 scopus 로고    scopus 로고
    • Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomized controlled trial
    • Vestbo J, Serensen T, Lange P, et al.: Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 1999, 353:1819-1823.
    • (1999) Lancet , vol.353 , pp. 1819-1823
    • Vestbo, J.1    Serensen, T.2    Lange, P.3
  • 21
    • 0345188819 scopus 로고    scopus 로고
    • Long-term treatment with inhaled b budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
    • Pauwels RA, Lofdahl CG, Laitinen LA, et al.: Long-term treatment with inhaled b budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999, 340:1948-1953.
    • (1999) N Engl J Med , vol.340 , pp. 1948-1953
    • Pauwels, R.A.1    Lofdahl, C.G.2    Laitinen, L.A.3
  • 23
    • 0032911831 scopus 로고    scopus 로고
    • Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A meta-analysis
    • van Grunsven PM, van Schayck CP, Derenne JP, et al.: Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax 1999, 54:7-14.
    • (1999) Thorax , vol.54 , pp. 7-14
    • Van Grunsven, P.M.1    Van Schayck, C.P.2    Derenne, J.P.3
  • 24
    • 0242577949 scopus 로고    scopus 로고
    • Contemporary management of chronic obstructive pulmonary disease
    • Sin DD, McAlister FA, Man SFP, et al.: Contemporary management of chronic obstructive pulmonary disease. JAMA 2003, 290:2301-2312. This is an excellent comprehensive meta-analysis that reviews all aspects of management of COPD.
    • (2003) JAMA , vol.290 , pp. 2301-2312
    • Sin, D.D.1    McAlister, F.A.2    Man, S.F.P.3
  • 25
    • 0037321260 scopus 로고    scopus 로고
    • Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: Dose the dose matter?
    • Sin DD, Man SFD: Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: dose the dose matter? Eur Respir J 2003, 21:260-266. This study uses a population database to evaluate survival and dose-relationship in patients treated with inhaled corticosteroids with COPD.
    • (2003) Eur Respir J , vol.21 , pp. 260-266
    • Sin, D.D.1    Man, S.F.D.2
  • 26
    • 0035880882 scopus 로고    scopus 로고
    • Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease
    • Sin DD, Tu JV: Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:580-584.
    • (2001) Am J Respir Crit Care Med , vol.164 , pp. 580-584
    • Sin, D.D.1    Tu, J.V.2
  • 27
    • 0036798266 scopus 로고    scopus 로고
    • Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice
    • Soriano JB, Vestbo J, Pride NB, et al.: Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002, 20:810-825. This analysis using a population database looks at survival benefit from combination therapy with fluticasone propionate and salmeterol.
    • (2002) Eur Respir J , vol.20 , pp. 810-825
    • Soriano, J.B.1    Vestbo, J.2    Pride, N.B.3
  • 28
    • 0041865230 scopus 로고    scopus 로고
    • Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: Immortal time bias in observational studies
    • Suissa S: Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 2003, 168:49-50. This study reviews potential biases of epidemiology studies, and shows that with alternative analysis, there is no survival benefit from inhaled corticosteroids.
    • (2003) Am J Respir Crit Care Med , vol.168 , pp. 49-50
    • Suissa, S.1
  • 29
    • 0036063208 scopus 로고    scopus 로고
    • The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A systematic review of randomized placebo-controlled trials
    • Alsaeedi A, Sin DD, McAlister FA: The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 2002, 113:59-65. This is an excellent comprehensive systematic review of randomized placebo-controlled trials of inhaled corticosteroids.
    • (2002) Am J Med , vol.113 , pp. 59-65
    • Alsaeedi, A.1    Sin, D.D.2    McAlister, F.A.3
  • 30
    • 0032515756 scopus 로고    scopus 로고
    • Multi-center randomised placebo controlled trial of inhaled fluticasone in patients with chronic obstructive pulmonary disease
    • Paggiaro PL, Dagle R, Bakran I, et al.: Multi-center randomised placebo controlled trial of inhaled fluticasone in patients with chronic obstructive pulmonary disease. Lancet 1998, 351:773-780.
    • (1998) Lancet , vol.351 , pp. 773-780
    • Paggiaro, P.L.1    Dagle, R.2    Bakran, I.3
  • 31
    • 0037246565 scopus 로고    scopus 로고
    • Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
    • On behalf of the ISOLDE study investigators
    • Jones PW, Willits LR, Burge PS, et al.: On behalf of the ISOLDE study investigators. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J 2003, 21:68-73. This is a post-hoc analysis that evaluates the effect of fluticasone propionate based on disease severity.
    • (2003) Eur Respir J , vol.21 , pp. 68-73
    • Jones, P.W.1    Willits, L.R.2    Burge, P.S.3
  • 32
    • 0033542041 scopus 로고    scopus 로고
    • Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis
    • Lipworth BJ: Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999, 159:941-995.
    • (1999) Arch Intern Med , vol.159 , pp. 941-995
    • Lipworth, B.J.1
  • 33
    • 0038498561 scopus 로고    scopus 로고
    • Lack of long-term adverse adrenal effects from inhaled triamcinolone
    • Eichenhorn MS, Wise RA, Madhok TC, et al.: Lack of long-term adverse adrenal effects from inhaled triamcinolone. Chest 2003, 124:57-62. This study evaluates inhaled triamcinolone's effect on adrenal suppression.
    • (2003) Chest , vol.124 , pp. 57-62
    • Eichenhorn, M.S.1    Wise, R.A.2    Madhok, T.C.3
  • 34
    • 0026754748 scopus 로고
    • Risk of osteoporosis in men with chronic bronchitis
    • Pract JP, Peretz A: Risk of osteoporosis in men with chronic bronchitis. Osteoporosis Int 1992, 2:257-261.
    • (1992) Osteoporosis Int , vol.2 , pp. 257-261
    • Pract, J.P.1    Peretz, A.2
  • 36
    • 0028811651 scopus 로고
    • Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
    • Hanania NA, Chapman KR, Sturtridge WC, et al.: Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995, 96:571-579.
    • (1995) J Allergy Clin Immunol , vol.96 , pp. 571-579
    • Hanania, N.A.1    Chapman, K.R.2    Sturtridge, W.C.3
  • 37
    • 0029884478 scopus 로고    scopus 로고
    • Bone density in asthmatic patients taking inhaled corticosteroids: Comparison of budesonide and beclomethasone dipropionate
    • Packe GE, Robb O, Robins SP, et al.: Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate. J Roy Coll Phys Lond 1996, 30:128-132.
    • (1996) J Roy Coll Phys Lond , vol.30 , pp. 128-132
    • Packe, G.E.1    Robb, O.2    Robins, S.P.3
  • 38
    • 0031825521 scopus 로고    scopus 로고
    • Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids
    • Ebeling PR, Erbas B, Hopper JL, et al.: Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Min Res 1998, 13:1283-1289.
    • (1998) J Bone Min Res , vol.13 , pp. 1283-1289
    • Ebeling, P.R.1    Erbas, B.2    Hopper, J.L.3
  • 39
    • 0034701480 scopus 로고    scopus 로고
    • Inhaled corticosteroid use and bone-mineral density in patients with asthma
    • Wong CA, Walsh U, Smith CJP, et al.: Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000, 355:1399-1403.
    • (2000) Lancet , vol.355 , pp. 1399-1403
    • Wong, C.A.1    Walsh, U.2    Smith, C.J.P.3
  • 40
    • 0031947795 scopus 로고    scopus 로고
    • Association between corticosteroid use and vertebral fractures in older men with chronic obstructive ease
    • McEvoy CE, Ensrud KE, Bender E, et al.: Association between corticosteroid use and vertebral fractures in older men with chronic obstructive ease. Am J Respir Crit Care Med 1998, 157:704-709.
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 704-709
    • McEvoy, C.E.1    Ensrud, K.E.2    Bender, E.3
  • 41
    • 0035991327 scopus 로고    scopus 로고
    • Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler ®
    • Johnell O, Pauwels R, Löfdahl C-G, et al.: Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler ®. Eur Respir J 2002, 19:1058-1063. This study evaluates the effect of budesonide on bone mineral density.
    • (2002) Eur Respir J , vol.19 , pp. 1058-1063
    • Johnell, O.1    Pauwels, R.2    Löfdahl, C.-G.3
  • 42
    • 0037111198 scopus 로고    scopus 로고
    • Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease
    • van der Valk P, Monninkhof E, van der Palen J, et al.: Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2002, 166:1358-1363. This study evaluates the effect of withdrawal of inhaled corticosteroids on respiratory symptoms and exacerbation rates.
    • (2002) Am J Respir Crit Care Med , vol.166 , pp. 1358-1363
    • Van Der Valk, P.1    Monninkhof, E.2    Van Der Palen, J.3
  • 43
    • 0034901163 scopus 로고    scopus 로고
    • Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells
    • Korn SH, Jerre A, Brattsand R: Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 2001, 17:1059-1061.
    • (2001) Eur Respir J , vol.17 , pp. 1059-1061
    • Korn, S.H.1    Jerre, A.2    Brattsand, R.3
  • 44
    • 0036191465 scopus 로고    scopus 로고
    • Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts
    • Spoelstra FM, Postma DS, Hovenga H, et al.: Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax 2002, 57:237-241.
    • (2002) Thorax , vol.57 , pp. 237-241
    • Spoelstra, F.M.1    Postma, D.S.2    Hovenga, H.3
  • 45
    • 0036153433 scopus 로고    scopus 로고
    • Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and oral corticosteroids
    • Barnes P: Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and oral corticosteroids. Eur Respir J 2002, 19:182-191.
    • (2002) Eur Respir J , vol.19 , pp. 182-191
    • Barnes, P.1
  • 46
    • 0037246566 scopus 로고    scopus 로고
    • Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
    • Szafranski W, Cukier A, Ramierez A, et al.: Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003, 21:74-81. This study compares key outcomes of pulmonary function, respiratory symptoms, quality of life, and exacerbation rate in patients on combination therapy with budesonide/formoterol versus monotherapy and placebo.
    • (2003) Eur Respir J , vol.21 , pp. 74-81
    • Szafranski, W.1    Cukier, A.2    Ramierez, A.3
  • 47
    • 0037425745 scopus 로고    scopus 로고
    • Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomized controlled trial
    • Calverley P, Pauwels R, Vestbo J, et al.: Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2003, 361:449-456. This study compares key outcomes of pulmonary function, respiratory symptoms, quality of life, and exacerbation rate in patients on combination therapy with budesonide/formoterol versus monotherapy and placebo.
    • (2003) Lancet , vol.361 , pp. 449-456
    • Calverley, P.1    Pauwels, R.2    Vestbo, J.3
  • 48
    • 0031001720 scopus 로고    scopus 로고
    • Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study
    • Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
    • (1997) Lancet , vol.349 , pp. 1498-1504
    • Murray, C.J.1    Lopez, A.D.2
  • 49
    • 0037336007 scopus 로고    scopus 로고
    • Costs of chronic bronchitis and COPD
    • Miravitlles M, Murio C, Guerrero T, et al.: Costs of chronic bronchitis and COPD. Chest 2003, 123:784-791.
    • (2003) Chest , vol.123 , pp. 784-791
    • Miravitlles, M.1    Murio, C.2    Guerrero, T.3
  • 51
    • 0035110276 scopus 로고    scopus 로고
    • The costs of treating COPD in the United States
    • Strassels SA, Smith DH, Sullivan SD, et al.: The costs of treating COPD in the United States. Chest 2001, 119:344-352.
    • (2001) Chest , vol.119 , pp. 344-352
    • Strassels, S.A.1    Smith, D.H.2    Sullivan, S.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.